HTG Molecular Diagnostics (HTGM) Reports Q4 Loss of $0.76/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts HTGM Hot Sheet
Join SI Premium – FREE
HTG Molecular Diagnostics (NASDAQ: HTGM) reported Q4 EPS of ($0.76), versus ($0.83) reported last year. Revenue for the quarter came in at $1.5 million, versus $1.22 million reported last year.
For earnings history and earnings-related data on HTG Molecular Diagnostics (HTGM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo starts On Holding at Overweight, sees growth reaccelerating in 2027
- Seagate Technology shares drop amid sector selloff
- Graphic Packaging Holding Company (GPK) PT Raised to $11.50 at UBS
Create E-mail Alert Related Categories
Earnings, Momentum MoversRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
